CASE REPORTS
Rhabdomyolysis Developing Secondary to Atorvastatin Therapy in a Patient with Liver Cirrhosis
2013 年 52 巻 7 号 p. 823-825
詳細
2013 年 52 巻 7 号 p. 823-825
Atorvastatin is a lipid lowering agent that is widely used worldwide. Rhabdomyolysis is a rare but serious side effect that may lead to renal failure and dangerous electrolyte abnormalities in patients with decreased hepatic clearance of atorvastatin. We herein report the case of a patient with liver cirrhosis receiving atorvastatin therapy for ischemic heart disease and hyperlipidemia who developed rhabdomyolysis and acute renal failure.
